TLR4 and hepatocellular carcinoma: The researchers incorporated lipopolysaccharide (LPS), a key component of Gram-negative bacteria and potent TLR4 activator known to modulate the tumor immune microenvironment, in their investigation of USP8-mediated hepatocellular carcinoma regulation.